Davis Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Davis Capital Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.99K	Hold	22	–	–	﹤0.01%	293
2026 Q2	$5.45K	Hold	22	–	–	﹤0.01%	310
2026 Q1	$4.42K	Hold	22	–	–	﹤0.01%	261
2025 Q4	$4.54K	Hold	22	–	–	﹤0.01%	267
2025 Q3	$3.94K	Buy	+22	New	+$3.75K	﹤0.01%	277
2025 Q1	$3.74K	Hold	22	–	–	﹤0.01%	272
2024 Q4	$3.66K	Hold	22	–	–	﹤0.01%	271
2024 Q3	$3.78K	Hold	22	–	–	﹤0.01%	286
2024 Q2	$3.38K	Buy	+22	New	+$3.3K	﹤0.01%	280

Other funds holding FBT

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.44B AUM 38.08% 1-Year Est. Return

D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return

Bensler Bellevue, Washington $1.06B AUM 29.38% 1-Year Est. Return

Csenge Advisory Group Clearwater, Florida $2.53B AUM 18.15% 1-Year Est. Return

NewSquare Capital Newtown Square, Pennsylvania $1.38B AUM 24% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return

Davis Capital Management's FBT Position: Q3 2026 in Review

Davis Capital Management held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q3 2026 at 22 shares worth $5.99K. The position accounts for ﹤0.01% of the portfolio, ranked #293.

Davis Capital Management first reported a position in FBT in Q2 2024 and has held it in 9 quarters since. 227 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

Davis Capital Management held 22 shares of First Trust NYSE Arca Biotechnology Index Fund worth $5.99K as of Q3 2026.
Davis Capital Management left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q3 2026.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Davis Capital Management's portfolio in Q3 2026, its #293 holding.
Davis Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2024 and has held it in 9 quarters since.
227 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.